Combination therapies 2 : biological response modifiers in the treatment of cancer and infectious diseases /
Saved in:
| Imprint: | New York : Plenum Press, c1993. |
|---|---|
| Description: | x, 256 p. : ill. ; 26 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/1578103 |
Table of Contents:
- 1. Cytokine Synergy in Immunotherapy / J. W. Hadden, P. Malec, A. Saha and E. M. Hadden
- 2. Monitoring Combination Therapy Trials: New Challenges for the Clinical Laboratory / J. L. Rossio, H. C. Rager, C. S. Goundry and W. J. Urba
- 3. IL-2-Based Consolidative Immunotherapy After Autologous Bone Marrow Transplantation / A. Fefer, M. C. Benyunes, C. Higuchi, A. York, C. Massumoto, C. G. Lindgren, C. D. Buckner and J. A. Thompson
- 4. Tumor Immunogenicity Induced by the Local Occurrence of IL-2 / F. Cavallo, F. Di Pierro, M. Giovarelli, A. Vacca, A. Gulino, A. Soppacciaro, A. Modesti and G. Forni
- 5. Thymosin [alpha][subscript 1]: Chemistry, Mechanism of Action and Clinical Applications / A. L. Goldstein
- 6. Combination Therapy with Thymosin [alpha][subscript 1] and Cytokines in the Treatment of Cancer and Infectious Diseases / E. Garaci, A. Mastino, F. Pica and C. Favalli
- 7. Effect of Thymosin [alpha][subscript 1] on Cocaine-induced Inhibition of T-Cell Dependent Murine Immune Response / G. Ravagnan, R. Falchetti, P. Di Francesco, R. Gaziano, G. Lanzilli, C. Favalli and E. Garaci
- 8. Regulation of Gene Expression by Interferons / S. Landolfo, M. Gariglio, M. Gaboli, D. Lembo, A. Caliendo and R. Cavallo
- 9. Interactions Between Tumor Necrosis Factor Alpha and Glucocorticoid Hormones in the Regulation of Tumor Cell Growth In Vitro / I. Nicoletti, G. Migliorati, M. C. Pagliacci, F. Grignani and C. Riccardi
- 10. Behavioural, Pyrogenic and Electrocortical Effects of Tumor Necrosis Factor-Alpha Given Intracerebrally in Rats / G. B. De Sarro, D. Rotiroti and G. Nistico
- 11. Biological Significance and Therapeutic Potential of Tumor-Associated Leukocytes / A. Mantovani, B. Bottazzi, S. Sozzani, G. Peri, P. Allavena, A. Vecchi and F. Colotta
- 12. Septic Shock Pathophysiology: Focus on Therapeutic Approach / G. Palmieri, G. Nicoletti, S. Cantoni and L. Bucci
- 13. Differentiating Agents and Cancer Therapy. Role of Cellular Lipid Peroxidation and its Product 4-Hydroxynonenal in the Control of Cell Proliferation and Differentiation / V. M. Fazio, G. Barrera, R. Muraca, M. Rinaldi, S. A. Ciafre, M. Lazzari, M. U. Dianzani and M. Giulia Farace
- 14. Inhibition of HIV Replication and Enhancement of Immune Functions by the Acyclic Nucleoside Phosphonate 9-(2-Phosphonyl-Methoxyethyl) Adenine (PMEA) / C. F. Perno, V. Del Gobbo, J. Balzarini, E. Balestra, G. Milanese, A. Holy, E. De Clercq, N. Villani and R. Calio
- 15. Modulation of Inflammatory Cytokines by a Receptor Antagonist, Autoantibodies, and Fever / K. Bendtzen, M. B. Hansen and M. Svenson
- 16. Cancer Immunochemotherapy: Preliminary Studies with Triazene Compounds / G. Graziani, S. D'Atri, A. Giuliani, A. Franchi, D. Piccioni, G. Papa and E. Bonmassar
- 17. Thymosin [alpha][subscript 1] and [alpha]-Interferon with Cisplatin and Etoposide in Advanced Non-Small Cell Lung Cancer: A Phase II Study / M. Lopez, G. Bonsignore, M. D'Aprile, C. Favalli, M. Della Giulia, L. Di Lauro, P. Vici and E. Garaci
- 18. Combination of Chronic Indomethacin and Intermittent IL-2 Therapy in the Treatment of Disseminated Cancer / P. K. Lala, N. Al-Mutter, R. Parhar, M. N. Saarloos, D. Banerjee, V. Bramwell and W. C. Mertens
- 19. Combination Chemotherapy and Cytokines in the Treatment of Advanced Primary Lung Cancer: Results of a Controlled Clinical Trial / G. S. Del Giacco, G. Mantovani, P. Lai, E. Turnu, F. Locci, A. C. Scanu and G. Pusceddu
- 20. Biological Response Modifiers and Differentiating Agents in Myelodisplastic Syndromes / A. Venditti, M. T. Scimo, G. Del Poeta, R. Stasi, U. Coppetelli, M. Masi, M. Cecconi, M. Tribalto, G. Papa, C. Favalli and E. Garaci
- 21. Myeloid Growth Factors in Cancer Treatment / A. Butturini and R. P. Gale
- 22. Efficacy of the Combined Treatment with Fluconazole and Thymosin [alpha][subscript 1] Against Candida albicans Infection in Morphine-Treated Mice / P. Di Francesco, R. Gaziano, F. Pica, I. Casalinuovo, A. T. Palamara, L. Belogi, C. Favalli and E. Garaci
- 23. Anti-Cytokine Therapy of Murine Candidiasis / L. Romani, E. Cenci, A. Mencacci, R. Spaccapelo, E. Schiaffella, L. Tonnetti, P. Puccetti and F. Bistoni
- 24. The Basic Research and Clinical Application of Thymopeptidin / C. X. Zheng, C. S. Xu and S. Liu
- 25. Treatment of Hepatitis C Virus-Associated Chronic Liver Disease with [beta]-Interferon and Inosine Pranobex: Combination Schedule vs. Monotherapies / D. Sansonno, C. Azzolini and F. Dammacco
- 26. Sustained Response to Thymosin Therapy in Patients with Chronic Active Hepatitis B / M. G. Mutchnick, J. I. Jaurequi and D. A. Shafritz
- 27. Combination Anti-HIV Therapy: Questions and Answers / T. C. Merigan
- 28. Mechanisms of Disease Progression and CD4 Depletion in HIV-1 Infection / F. Aiuti, E. Scala, I. Mezzaroma, G. P. D'Offizi, R. Ferrara, G. Ricci and F. Pandolfi
- 29. Combined Therapy with Zidovudine, Thymosin [alpha][subscript 1] and [alpha]-Interferon in the Treatment of HIV-Infected Patients / E. Garaci, G. Rocchi, L. Perroni, C. D'Agostini, F. Soscia, A. Mastino, S. Grelli, C. F. Perno and C. Favalli
- 30. The Problem of Interferon Species Appearing in Patients with Autoimmune Diseases / L. Borecky, V. Lackovic, P. Kontsek, N. Fuchsberger, M. Kubes and J. Rovensky.
